J. Smith

Safety and pharmacokinetics of oseltamivir at standard and high dosages.

B. Davies, R. Dutkowski, James R. Smith, 2010, International journal of antimicrobial agents.

Roche perspectives on Tamiflu.

B. Clinch, J. Smith, 2015, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Active metabolite from Tamiflu solution is bioequivalent to that from capsule delivery in healthy volunteers: a cross-over, randomised, open-label study.

R. Robson, R. Dutkowski, M. Brewster, 2006, Vaccine.

Incidence of neuropsychiatric adverse events in influenza patients treated with oseltamivir or no antiviral treatment

S. Sacks, J. Smith, 2009, International journal of clinical practice.